169 related articles for article (PubMed ID: 22007275)
21. A critical review of studies on vitamin D in relation to colorectal cancer.
Grant WB; Garland CF
Nutr Cancer; 2004; 48(2):115-23. PubMed ID: 15231446
[TBL] [Abstract][Full Text] [Related]
22. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).
Giovannucci E
Cancer Causes Control; 2005 Mar; 16(2):83-95. PubMed ID: 15868450
[TBL] [Abstract][Full Text] [Related]
23. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
24. Associations between common polymorphisms in CYP2R1 and GC, Vitamin D intake and risk of colorectal cancer in a prospective case-cohort study in Danes.
Kopp TI; Vogel U; Andersen V
PLoS One; 2020; 15(2):e0228635. PubMed ID: 32012190
[TBL] [Abstract][Full Text] [Related]
25. Insufficient vitamin D supply as a possible co-factor in colorectal carcinogenesis.
Sieg J; Sieg A; Dreyhaupt J; Schmidt-Gayk H
Anticancer Res; 2006; 26(4A):2729-33. PubMed ID: 16886684
[TBL] [Abstract][Full Text] [Related]
26. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.
Moukayed M; Grant WB
Rev Endocr Metab Disord; 2017 Jun; 18(2):167-182. PubMed ID: 28213657
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force.
Chung M; Lee J; Terasawa T; Lau J; Trikalinos TA
Ann Intern Med; 2011 Dec; 155(12):827-38. PubMed ID: 22184690
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of vitamin D and colorectal cancer.
Giovannucci E
Anticancer Agents Med Chem; 2013 Jan; 13(1):11-9. PubMed ID: 23094917
[TBL] [Abstract][Full Text] [Related]
29. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.
Platz EA; Hankinson SE; Hollis BW; Colditz GA; Hunter DJ; Speizer FE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1059-65. PubMed ID: 11045788
[TBL] [Abstract][Full Text] [Related]
30. 1α,25-Dihydroxyvitamin D
Ben-Eltriki M; Deb S; Guns EST
J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
[TBL] [Abstract][Full Text] [Related]
31. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
Leyssens C; Verlinden L; Verstuyf A
Endocr Relat Cancer; 2013 Apr; 20(2):R31-47. PubMed ID: 23319494
[TBL] [Abstract][Full Text] [Related]
32. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas.
Peters U; McGlynn KA; Chatterjee N; Gunter E; Garcia-Closas M; Rothman N; Sinha R
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1267-74. PubMed ID: 11751444
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D status and ill health: a systematic review.
Autier P; Boniol M; Pizot C; Mullie P
Lancet Diabetes Endocrinol; 2014 Jan; 2(1):76-89. PubMed ID: 24622671
[TBL] [Abstract][Full Text] [Related]
35. Calcium plus vitamin D supplementation and the risk of colorectal cancer.
Wactawski-Wende J; Kotchen JM; Anderson GL; Assaf AR; Brunner RL; O'Sullivan MJ; Margolis KL; Ockene JK; Phillips L; Pottern L; Prentice RL; Robbins J; Rohan TE; Sarto GE; Sharma S; Stefanick ML; Van Horn L; Wallace RB; Whitlock E; Bassford T; Beresford SA; Black HR; Bonds DE; Brzyski RG; Caan B; Chlebowski RT; Cochrane B; Garland C; Gass M; Hays J; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Jackson RD; Johnson KC; Judd H; Kooperberg CL; Kuller LH; LaCroix AZ; Lane DS; Langer RD; Lasser NL; Lewis CE; Limacher MC; Manson JE;
N Engl J Med; 2006 Feb; 354(7):684-96. PubMed ID: 16481636
[TBL] [Abstract][Full Text] [Related]
36. Plasma vitamin D metabolites and risk of colorectal cancer in women.
Feskanich D; Ma J; Fuchs CS; Kirkner GJ; Hankinson SE; Hollis BW; Giovannucci EL
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1502-8. PubMed ID: 15342452
[TBL] [Abstract][Full Text] [Related]
37. Early 1,25-Dihydroxyvitamin D
Tian LQ; Yu YT; Jin MD; Duan HL; Huang G; Zhang ML
J Nutr Sci Vitaminol (Tokyo); 2021; 67(2):84-90. PubMed ID: 33952739
[TBL] [Abstract][Full Text] [Related]
38. Optimizing vitamin D status to reduce colorectal cancer risk: an evidentiary review.
Zhou G; Stoitzfus J; Swan BA
Clin J Oncol Nurs; 2009 Aug; 13(4):E3-E17. PubMed ID: 19648087
[TBL] [Abstract][Full Text] [Related]
39. 25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies.
Ekmekcioglu C; Haluza D; Kundi M
Int J Environ Res Public Health; 2017 Jan; 14(2):. PubMed ID: 28134804
[TBL] [Abstract][Full Text] [Related]
40. Dietary 1,25-dihydroxycholecalciferol has variable effects on the incidences of leg abnormalities, plasma vitamin D metabolites, and vitamin D receptors in chickens divergently selected for tibial dyschondroplasia.
Mitchell RD; Edwards HM; McDaniel GR; Rowland GN
Poult Sci; 1997 Feb; 76(2):338-45. PubMed ID: 9057217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
